BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Deals

  Galapagos NV Reaches Agreement to Acquire GlaxoSmithKline Research Centre In Zagreb, Croatia For €14 Million ($17.8 Million); Includes Transfer Of Approximately 130 Staff

  September 8, 2010

   · 

  1 min read
• Drug Development

  Progenics Pharmaceuticals, Inc. Initiates Oral Methylnaltrexone Phase 3 Trial in Patients with Chronic Non-Cancer Pain

  September 8, 2010

   · 

  1 min read
• Drug Development

  ImmunoCellular Therapeutics, Ltd Announces Long-Term Disease-Free Survival Data from Phase I Study in Glioblastoma

  September 8, 2010

   · 

  1 min read
• Business

  Pharmaca Integrative Pharmacy Announces 23rd Location Opening in Menlo Park, Calif. this November

  September 8, 2010

   · 

  1 min read
• Policy

  Teva Pharmaceutical Industries Limited Wins Ruling Over Copaxone Patents

  September 8, 2010

   · 

  1 min read
• Business

  Elekta’s Interim Report May-July 2010/11

  September 8, 2010

   · 

  1 min read
• Drug Development

  N30 Pharma Initiates Phase 1 Trials of Novel Reductase Inhibitor

  September 8, 2010

   · 

  2 min read
• Business

  Cmed Appoints Andrew Kellett as Chief Financial Officer

  September 8, 2010

   · 

  1 min read
• Drug Development

  GE Healthcare Release: Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology

  September 8, 2010

   · 

  3 min read
• Drug Development

  ReVision Optics, Inc. Finishes Phase One of FDA Clinical Trial

  September 8, 2010

   · 

  1 min read